PCPLA43 Stock Latest News
Private CompaniesCold Plasma Therapy Highlighted in Venous Leg Ulcer Case Study4d agoPLA43
Private CompaniesCold Plasma Therapy Adoption Highlights Plasmacure’s Position in Chronic Wound Care1w agoPLA43
Private CompaniesPlasmacure Highlights Cold Plasma Approach for Chronic Wound Biofilms2w agoPLA43
Private CompaniesPlasmacure Highlights Clinical Evidence and Economics for Cold Plasma Wound Therapy3w agoPLA43
Private CompaniesFinance Leadership Underscores Plasmacure’s Focus on Scalable Growth1M agoPLA43
Private CompaniesClinical Case Highlights PLASOMA Use in Chronic Diabetic Foot Ulcer1M agoPLA43
- Private CompaniesCold Plasma Wound Therapy Research Progress Highlights Plasmacure’s Clinical Focus1M agoPLA43
Private CompaniesPlasmacure Highlights PLASOMA Wound Care Outcomes and Cost-Saving Potential2M agoPLA43- Private CompaniesPlasmacure Highlights Productivity Gains From Cold Plasma Wound Therapy2M agoPLA43
Private CompaniesPlasmacure Positions PLASOMA for Early Intervention in Complex Wound Care2M agoPLA43Private CompaniesPlasmacure Highlights Caregiver Impact in Chronic Wound Management Strategy2M agoPLA43
- Private CompaniesPlasmacure – Weekly Recap3M agoPLA43
Private CompaniesPlasmacure Highlights Clinical and Cost Advantages of PLASOMA Wound Therapy3M agoPLA43- Private CompaniesEducational Emphasis on Patient Misconceptions Signals Strategic Focus in Wound Care3M agoPLA43
Private CompaniesPlasmacure Highlights Market Opportunity in Chronic Wound Care With PLASOMA Therapy3M agoPLA43
Private CompaniesCold Plasma Wound Therapy Developer Highlights CE-Certified Device and Trial Outcomes4M agoPLA43